- GLP-1 Medications Force Food Industry Rethink IFT.org
- The Ozempic movement: Can restaurants survive in the new age of weight-loss drugs? The Caterer
- The Weight of Progress: A New Era Dawns for Anti-Obesity Drugs, Reshaping Markets and Health FinancialContent
- America’s obsession with Ozempic wng.org
- Ozempic Is The New Botox – And Novo, Eli Lilly Are Printing Billions – Novo Nordisk (NYSE:NVO), Eli Lilly (NYSE:LLY) Benzinga